Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study
Background: Dengue infection is an arboviral disease that could lead to severe illness. The incidence of severe dengue will impact patients' financial aspects. As an important clinical feature, platelet level on admission day might contribute to the direct medical cost. Objective: This study ai...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Faculty of Pharmacy, Universitas Airlangga
2022-08-01
|
| Series: | Jurnal Farmasi dan Ilmu Kefarmasian Indonesia |
| Subjects: | |
| Online Access: | https://e-journal.unair.ac.id/JFIKI/article/view/33382 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849405962947919872 |
|---|---|
| author | Imaniar Noor Faridah Tuty Lia Syahfitri Reza Aditya Nugroho Woro Supadmi Haafizah Dania Dyah Aryani Perwitasari |
| author_facet | Imaniar Noor Faridah Tuty Lia Syahfitri Reza Aditya Nugroho Woro Supadmi Haafizah Dania Dyah Aryani Perwitasari |
| author_sort | Imaniar Noor Faridah |
| collection | DOAJ |
| description | Background: Dengue infection is an arboviral disease that could lead to severe illness. The incidence of severe dengue will impact patients' financial aspects. As an important clinical feature, platelet level on admission day might contribute to the direct medical cost. Objective: This study aimed to examine the direct medical cost among patients with dengue fever (DF) or dengue hemorrhagic fever (DHF) in Yogyakarta, Indonesia. Methods: This study was a retrospective study conducted in two private hospitals in Yogyakarta, Indonesia. Participants included in this study were hospitalized patients diagnosed with DF or DHF. Data were extracted from medical records and finance departments in each hospital. Results: Among 174 dengue patients included in this study, the mean age of DHF patients (18.44 + 14.87) was lower than in DF patients (23.47 + 18.99). Patients with DHF (4.88 days) also showed prolonged hospitalization compared with DF (4.18 days) patients. In terms of medical cost, DHF patients need a higher dengue treatment cost, which is about 329.74 USD compared to 220.68 USD for DF patients in hospital 2. Mainly related to room charges, which increased by 9.48% in hospital 1 and 66.28% in hospital 2 compared with DF patients. Furthermore, DHF patients with thrombocytopenia on the first day of admission present higher medical costs in terms of laboratory fees (36.08%), medicine (18.17%), and total medical costs (9.84%). Conclusion: Severe form of dengue will contribute to economic burden. Therefore, prevention and adequate treatment are essential to reduce the prognosis of severe dengue and higher medical cost. |
| format | Article |
| id | doaj-art-bf9b4e29950f43bab41d175bee68d33a |
| institution | Kabale University |
| issn | 2406-9388 2580-8303 |
| language | Indonesian |
| publishDate | 2022-08-01 |
| publisher | Faculty of Pharmacy, Universitas Airlangga |
| record_format | Article |
| series | Jurnal Farmasi dan Ilmu Kefarmasian Indonesia |
| spelling | doaj-art-bf9b4e29950f43bab41d175bee68d33a2025-08-20T03:36:32ZindFaculty of Pharmacy, Universitas AirlanggaJurnal Farmasi dan Ilmu Kefarmasian Indonesia2406-93882580-83032022-08-019217718410.20473/jfiki.v9i22022.177-18427395Direct Medical Cost Analysis of Dengue Patients: A Retrospective StudyImaniar Noor Faridah0Tuty Lia Syahfitri1Reza Aditya Nugroho2Woro Supadmi3Haafizah Dania4Dyah Aryani Perwitasari5Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, IndonesiaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, IndonesiaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, IndonesiaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, IndonesiaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, IndonesiaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, IndonesiaBackground: Dengue infection is an arboviral disease that could lead to severe illness. The incidence of severe dengue will impact patients' financial aspects. As an important clinical feature, platelet level on admission day might contribute to the direct medical cost. Objective: This study aimed to examine the direct medical cost among patients with dengue fever (DF) or dengue hemorrhagic fever (DHF) in Yogyakarta, Indonesia. Methods: This study was a retrospective study conducted in two private hospitals in Yogyakarta, Indonesia. Participants included in this study were hospitalized patients diagnosed with DF or DHF. Data were extracted from medical records and finance departments in each hospital. Results: Among 174 dengue patients included in this study, the mean age of DHF patients (18.44 + 14.87) was lower than in DF patients (23.47 + 18.99). Patients with DHF (4.88 days) also showed prolonged hospitalization compared with DF (4.18 days) patients. In terms of medical cost, DHF patients need a higher dengue treatment cost, which is about 329.74 USD compared to 220.68 USD for DF patients in hospital 2. Mainly related to room charges, which increased by 9.48% in hospital 1 and 66.28% in hospital 2 compared with DF patients. Furthermore, DHF patients with thrombocytopenia on the first day of admission present higher medical costs in terms of laboratory fees (36.08%), medicine (18.17%), and total medical costs (9.84%). Conclusion: Severe form of dengue will contribute to economic burden. Therefore, prevention and adequate treatment are essential to reduce the prognosis of severe dengue and higher medical cost.https://e-journal.unair.ac.id/JFIKI/article/view/33382dengueinfectionmedical cost |
| spellingShingle | Imaniar Noor Faridah Tuty Lia Syahfitri Reza Aditya Nugroho Woro Supadmi Haafizah Dania Dyah Aryani Perwitasari Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study Jurnal Farmasi dan Ilmu Kefarmasian Indonesia dengue infection medical cost |
| title | Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study |
| title_full | Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study |
| title_fullStr | Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study |
| title_full_unstemmed | Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study |
| title_short | Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study |
| title_sort | direct medical cost analysis of dengue patients a retrospective study |
| topic | dengue infection medical cost |
| url | https://e-journal.unair.ac.id/JFIKI/article/view/33382 |
| work_keys_str_mv | AT imaniarnoorfaridah directmedicalcostanalysisofdenguepatientsaretrospectivestudy AT tutyliasyahfitri directmedicalcostanalysisofdenguepatientsaretrospectivestudy AT rezaadityanugroho directmedicalcostanalysisofdenguepatientsaretrospectivestudy AT worosupadmi directmedicalcostanalysisofdenguepatientsaretrospectivestudy AT haafizahdania directmedicalcostanalysisofdenguepatientsaretrospectivestudy AT dyaharyaniperwitasari directmedicalcostanalysisofdenguepatientsaretrospectivestudy |